Illumina Inc. Share Price Today: Live Updates & Key Insights

Illumina Inc. share price today is $125.93, up -1.79%. The stock opened at $127.59 against the previous close of $126.59, with an intraday high of $127.66 and low of $123.115.

Illumina Inc. Share Price Chart

Illumina Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Illumina Inc. Share Price Performance

$125.93 -0.0179(-1.79%) ILMN at 23 Mar 2026 01:38 PM Diagnostics & Research
Lowest Today 123.115
Highest Today 127.66
Today’s Open 127.59
Prev. Close 126.59
52 Week High 155.53
52 Week Low 68.70
Day’s Range: Low 123.115 High 127.66
52-Week Range: Low 68.70 High 155.53
1 day return -
1 Week return +4.2
1 month return +3.13
3 month return -9.71
6 month return +22.49
1 year return +41.21
3 year return -42.97
5 year return -71.06
10 year return -

Illumina Inc. Institutional Holdings

Capital World Investors 13.15

BlackRock Inc 12.22

Vanguard Group Inc 9.39

American Funds Growth Fund of Amer A 4.06

Capital Group Growth Fnd of Amer Comp 4.06

State Street Corp 3.92

iShares Core S&P Mid-Cap ETF 3.23

Vanguard Total Stock Mkt Idx Inv 2.99

AQR Capital Management LLC 2.89

Loomis, Sayles & Company LP 2.73

WCM Investment Management 2.66

Corvex Management LP 2.50

Sessa Capital, L.P 2.23

Vanguard Small Cap Index 2.15

Geode Capital Management, LLC 1.88

American Funds New Economy A 1.75

Capital Group New Economy Comp 1.75

American Funds American Balanced A 1.69

Vanguard Small Cap Value Index Inv 1.38

HHG PLC 1.33

PRIMECAP Management Company 1.30

American Funds New Perspective A 1.26

Capital Group New Perspective Comp 1.26

American Funds Washington Mutual A 1.24

Capital Group Wash Mutual Invtrs Comp 1.24

Bank of America Corp 1.24

Southpoint Capital Advisors LP 1.14

FMR Inc 1.11

Bank of New York Mellon Corp 1.10

JPMorgan Chase & Co 1.09

Vanguard Institutional Extnd Mkt Idx Tr 1.08

Baillie Gifford & Co Limited. 1.06

UBS Asset Mgmt Americas Inc 1.04

Northern Trust Corp 1.04

Invesco S&P MidCap Quality ETF 0.97

Janus Henderson Enterprise D 0.88

Janus Inst Mid Cap Growth CF 0.88

Vanguard Capital Opportunity Inv 0.80

Loomis Sayles Growth Y 0.73

iShares Biotechnology ETF 0.73

Illumina Inc. Market Status

Strong Buy: 7

Buy: 5

Hold: 11

Sell: 2

Strong Sell: 0

Illumina Inc. Fundamentals

Market Cap 19010.06 M

PB Ratio 7.1082

PE Ratio 23.1959

Enterprise Value 20275.61 M

Total Assets 6644.00 M

Volume 2663974

Illumina Inc. Company Financials

Annual Revenue FY25:4342000000 4342.0M, FY24:4372000000 4372.0M, FY23:4504000000 4504.0M, FY22:4584000000 4584.0M, FY21:4526000000 4526.0M

Annual Profit FY25:2887000000 2887.0M, FY24:2861000000 2861.0M, FY23:2744000000 2744.0M, FY22:2972000000 2972.0M, FY21:3154000000 3154.0M

Annual Net worth FY25:850000000 850.0M, FY24:-1223000000 -1223.0M, FY23:-1161000000 -1161.0M, FY22:-4404000000 -4404.0M, FY21:762000000 762.0M

Quarterly Revenue Q4/2025:1159000000 1159.0M, Q3/2025:1083000000 1083.0M, Q2/2025:1059000000 1059.0M, Q1/2025:1041000000 1041.0M, Q4/2024:1104000000 1104.0M

Quarterly Profit Q4/2025:777000000 777.0M, Q3/2025:732000000 732.0M, Q2/2025:695000000 695.0M, Q1/2025:683000000 683.0M, Q4/2024:728000000 728.0M

Quarterly Net worth Q4/2025:334000000 334.0M, Q3/2025:150000000 150.0M, Q2/2025:235000000 235.0M, Q1/2025:131000000 131.0M, Q4/2024:187000000 187.0M

About Illumina Inc. & investment objective

Company Information Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Organisation Diagnostics & Research

Employees 8600

Industry Diagnostics & Research

CEO Mr. Jacob Thaysen Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Illumina Inc. FAQs

What is the share price of Illumina Inc. today?

The current share price of Illumina Inc. is $125.93.

Can I buy Illumina Inc. shares in India?

Yes, Indian investors can buy Illumina Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Illumina Inc. shares in India?

You can easily invest in Illumina Inc. shares from India by:

Can I buy fractional shares of Illumina Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Illumina Inc.?

Illumina Inc. has a market cap of $19010.06 M.

In which sector does Illumina Inc. belong?

Illumina Inc. operates in the Diagnostics & Research sector.

What documents are required to invest in Illumina Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Illumina Inc.?

The PE ratio of Illumina Inc. is 23.20 and the PB ratio is 7.11.